Yingyan Yu

23.5k total citations · 1 hit paper
219 papers, 5.4k citations indexed

About

Yingyan Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yingyan Yu has authored 219 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 64 papers in Oncology and 53 papers in Cancer Research. Recurrent topics in Yingyan Yu's work include Epigenetics and DNA Methylation (31 papers), Cancer-related gene regulation (27 papers) and Cancer-related molecular mechanisms research (24 papers). Yingyan Yu is often cited by papers focused on Epigenetics and DNA Methylation (31 papers), Cancer-related gene regulation (27 papers) and Cancer-related molecular mechanisms research (24 papers). Yingyan Yu collaborates with scholars based in China, United States and Japan. Yingyan Yu's co-authors include Bingya Liu, Zhenggang Zhu, Qu Cai, Zhenggang Zhu, Liping Su, Xuehua Chen, Beiqin Yu, Jianfang Li, Jun Zhang and Ruixin Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and PLoS ONE.

In The Last Decade

Yingyan Yu

207 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial Convolutional Neural Network in Object Detection and Semantic Segmentation for Medical Imaging Analysis

2021 189 citations Yingyan Yu et al. profile →

Peers

Countries citing papers authored by Yingyan Yu

Since Specialization

Citations

This map shows the geographic impact of Yingyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingyan Yu more than expected).

Fields of papers citing papers by Yingyan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingyan Yu. The network helps show where Yingyan Yu may publish in the future.

Co-authorship network of co-authors of Yingyan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingyan Yu. A scholar is included among the top collaborators of Yingyan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingyan Yu. Yingyan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The application of organoids in investigating immune evasion in the microenvironment of gastric cancer and screening novel drug candidates 2025 ·Molecular Cancer ·(unknown), Yingyan Yu, Yan‐Jiang Wang, Lei Shi, Tao Fan, Hui Chen, Chuanli Ren	5
2	Remarkable Enhancement of the Radiotherapeutic Efficacy via Targeted Reduction of Hypoxic Conditions and Depletion of Intracellular Glutathione Utilizing Cu_2–xSe@Pt Nanoplatforms 2025 ·ACS Materials Letters ·(unknown), Peng Yang, Yingyan Yu, (unknown), Haoyan Cheng, (unknown), Fengqi Zhang, Wenxuan Fan, Hao Hu, Shegan Gao, Linlin Shi, Yan Yan, Kwun Nam Hui, Mingkai Liu	1
3	Tubeimoside-I, an inhibitor of HSPD1, enhances cytotoxicity of oxaliplatin by activating ER stress and MAPK signaling pathways in colorectal cancer 2024 ·Journal of Ethnopharmacology ·Tao Wu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yingyan Yu, (unknown), Zhong Lin Wang, Ri Cui, Yihu Zheng	6
4	Structure-aware deep model for MHC-II peptide binding affinity prediction 2024 ·BMC Genomics ·Yingyan Yu, (unknown), (unknown), Yafang Wu, Yinglin Wang, Midie Xu, Qing Liu	5
5	Paired organoids from primary gastric cancer and lymphatic metastasis are useful for personalized medicine 2024 ·Journal of Translational Medicine ·Ruixin Yang, (unknown), (unknown), Yutong Du, Ranlin Yan, Lu Zang, Xuexin Yao, Chen Li, (unknown), (unknown), Hengjun Gao, Io Hong Cheong, Zisis Kozlakidis, Yingyan Yu	9
6	GRP94 promotes anoikis resistance and peritoneal metastasis through YAP/TEAD1 pathway in gastric cancer 2024 ·iScience ·(unknown), (unknown), (unknown), Ruixin Yang, (unknown), Ranlin Yan, Yingyan Yu, Zhenqiang Wang, Chen Li	3
7	Patient-derived organoids in translational oncology and drug screening 2023 ·Cancer Letters ·Ruixin Yang, Yingyan Yu	64
8	Clinical and Molecular Characterization of a Patient with Generalized Arterial Calcification of Infancy Caused by Rare ABCC6 Mutation 2023 ·Journal of Personalized Medicine ·(unknown), Fan Yang, (unknown), Tingting Yu, Yingyan Yu, Guoying Chang, Xiumin Wang	1
9	<p>Influence of thoracic drainage fluid on proliferation, migration, apoptosis, and drug resistance in lung cancer cell lines</p> 2019 ·Cancer Management and Research ·(unknown), Yingyan Yu, (unknown)	1
10	HUPAN: a pan-genome analysis pipeline for human genomes 2019 ·Genome biology ·(unknown), (unknown), Jinyuan Lu, Huimin Lu, Wenmin Zhang, (unknown), Chen Sun, Zhiqiang Hu, Zhen Zhang, Guichao Li, Hongzhuan Chen, Zhen Xiang, Zhenggang Zhu, Hongyu Zhao, Yingyan Yu, Chaochun Wei	47
11	Pulmonary CCR2⁺CD4⁺T cells are immune regulatory and attenuate lung fibrosis development 2017 ·Thorax ·Katrin Milger, Yingyan Yu, (unknown), Martin Irmler, Alla Skapenko, Michael Mayinger, Mareike Lehmann, Johannes Beckers, Frank Reichenberger, Jürgen Behr, Oliver Eickelberg, Mélanie Königshoff, Susanne Krauss‐Etschmann	28
12	A new molecular classification of gastric cancer proposed by Asian Cancer Research Group (ACRG) 2016 ·Yingyan Yu	2
13	Aberrant promoter methylation of the CD4 gene in peripheral blood cells of mastitic dairy cows 2013 ·Genetics and Molecular Research ·(unknown), Ying Zhang, Yanghua He, Peipei Ma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jiuzhou Song, Yingyan Yu	29
14	Novel single nucleotide polymorphisms of the bovine methyltransferase 3b gene and their association with meat quality traits in beef cattle 2012 ·Genetics and Molecular Research ·X. Liu, Xiangyu Guo, (unknown), Meng Wu, (unknown), (unknown), Peipei Ma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yingyan Yu	9
15	Down-regulation of promoter methylation level of CD4 gene after MDV infection in MD-susceptible chicken line 2011 ·BMC Proceedings ·Juan Luo, Yingyan Yu, Huanmin Zhang, Fei Tian, Shuang Chang, Hans H. Cheng, Jiuzhou Song	29
16	A Novel Plant Homeodomain Finger 10–Mediated Antiapoptotic Mechanism Involving Repression of Caspase-3 in Gastric Cancer Cells 2010 ·Molecular Cancer Therapeutics ·Min Wei, Bingya Liu, Liping Su, Jianfang Li, Jun Zhang, Yingyan Yu, Min Yan, Zhongyin Yang, Xuehua Chen, Jiayun Liu, Xin Lv, Hui Nie, Qing Zhang, Zhong Zheng, Beiqin Yu, Jun Ji, Jianian Zhang, Zhenggang Zhu, Qinlong Gu	21
17	NF-κB as a molecular target in adjuvant therapy of gastrointestinal carcinomas 2004 ·European Journal of Surgical Oncology ·Yingyan Yu, (unknown), Zhenggang Zhu	20
18	Vascular Endothelial Growth Factor C Expression in Gastric Carcinoma and Its Relationship with Lymph Node Metastasis 2004 ·The Chinese-German Journal of Clinical Oncology ·Chao Yan, (unknown), Jun Ji, Yingyan Yu, Yi Zhang, (unknown), Bingya Liu, Zhenggang Zhu	3
19	Application of Banff schema in grading acute rejection following transplantation 2003 ·Yingyan Yu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
20	Molecular cloning and functional primary study of a novel candidate tumor suppressor gene related with nasopharyngeal carcinoma 2000 ·PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS ·Yingyan Yu, Yi Xie, Cao Li, Bicheng Zhang, Ming Zhou, Fenghuang Zhan, Guiyuan Li	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact